P018 Anti-Carbamylated Protein Antibodies as a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept
doi 10.1136/annrheumdis-2018-ewrr2019.13
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism